Thus, CXCL12 and CXCL13/CXCR5 expression in the LNs of these breast cancer patients may be more relevant than other chemokines or receptors studied for LN involvement, resulting in a worse prognosis.171. The gene discussed is CXCR5; the disease is breast carcinoma.